FRTX — Fresh Tracks Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $5.59m
- -$5.28m
- $8.01m
- 25
- 65
- 76
- 56
Annual cashflow statement for Fresh Tracks Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.9 | -20.9 | -39.5 | -21.1 | -5.69 |
| Depreciation | |||||
| Non-Cash Items | 1.5 | 2.52 | 3.86 | 2.21 | 1.98 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -13.6 | -1.65 | -0.556 | -0.478 | -0.669 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -36 | -20 | -36.1 | -19.3 | -4.34 |
| Capital Expenditures | -0.007 | -0.023 | -0.036 | -0.047 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 32.5 | 4.5 | 0 | — | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 32.5 | 4.48 | -0.036 | -0.047 | 0 |
| Financing Cash Flow Items | 0 | — | -0.051 | -0.055 | -0.038 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.64 | 38.4 | 33 | 1.18 | 6.53 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.835 | 22.9 | -3.23 | -18.2 | 2.19 |